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Previewsof differential H3K27me3 at the Lov-1
and Col alleles (Buzas et al., 2011).
The interaction of several SNPs,
including others located outside the
nucleation region, likely accounts for a
complex effect in PHD-PRC2 nucleation,
persistent histone modification, and
FLC expression. Recent genome-wide
scans have identified selective sweeps
that are correlated with climate-related
traits and genes, particularly flowering,
suggesting that positive selection of
new mutations played an important role
in climate adaptation (Hancock et al.,
2011; Horton et al., 2012). Now, the
identification of a handful of SNPs that
quantitatively affect the vernalization
requirement offers the possibility to study
some of these evolutionary dynamics
in greater detail. Encouragingly, the
distribution of these four SNPs in other
accessions of A. thaliana shows that
two of these polymorphisms are signifi-
cantly associated with the vernalization
response.454 Developmental Cell 23, September 11, 20Mutations in the cis-regulatory ele-
ments of genes are a major driving force
in evolution (Carroll, 2008; De Robertis,
2008; Pires and Dolan, 2012). An endless
number of themes and variations can
theoretically arise from the quantitative
modulation of the expression of only
a few genes. A key to the success of
A. thaliana, a cosmopolitan species that
has colonized a wide range of habitats,
was the ability to adjust the flowering
response to the local climate. The recali-
bration of the FLC switch nicely illustrates
the apparent simplicity with which a few
changes in the noncoding sequences of
one gene can quantitatively modulate
chromatin modification and alter the
timing of reproductive development,
thus allowing a species to thrive under
very diverse climatic conditions.REFERENCES
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Proteins are degraded from the ER by endoplasmic reticulum-associated degradation (ERAD). In a recent
issue ofMolecular Cell, Fleig et al. (2012) describe a role for a ubiquitin-binding rhomboid protease, RHBDL4,
in degradation of select ERAD substrates. These findings and the significance of rhomboids and other
intramembrane proteases are discussed.Intracellular protein degradation occurs
predominantly through two routes. Intra-
lumenal degradation takes place primarily
in lysosome-derived structures either by
trafficking through the secretory and en-
docytic pathways or as a consequence
of autophagy; both of these involve ubiq-
uitination. The second mechanism is
through often exquisitely regulated degra-
dation by the ubiquitin proteasome
system (UPS). One of the major sitesfrom which proteins are targeted for
degradation is the endoplasmic reticulum
(ER). Up to a third of proteins are translo-
cated into the ER, where they are modi-
fied (e.g., N-glycosylation, signal peptide
cleavage, proline isomerization, disulfide
bond formation), folded into native
conformations with the assistance of
chaperones, and assembled into
multiprotein complexes. Proteins that
successfully navigate these hurdles eitherare secreted or take up residence in the
secretory pathway, in the endocytic-
lysosomal pathway, or at the plasma
membrane. Managing this complexity
requires efficient means for degrading
misfolded or excess proteins. It was orig-
inally thought that this ‘‘quality control’’
occurred through intralumenal proteases
in the ER or another pre-Golgi com-
partment. We now know that such degra-
dation (ER-associated degradation, or
Figure 1. Rhomboid-like Proteins in ERAD
Degradation of proteins from the ER requires their ubiquitination, generally
with chains of ubiquitin, dislocation from the membrane, and proteasomal
degradation.
Left: The degradation of many substrates via the classical ERAD pathway
involves the ER membrane protein Derlin-1, which is associated with several
ERAD ubiquitin ligases (not shown). Derlin-1 also interacts with the p97
complex and promotes substrate dislocation from the ER membrane. The
transmembrane domains of Derlin-1 have homology to the rhomboid prote-
ases, making it a rhomboid pseudo-protease.
Center: The iRhoms are inactive homologs of the rhomboid proteases. Initial
studies of mammalian iRhoms suggest that they affect substrate trafficking
by enhancing the ERAD of membrane-tethered EGF ligand. Mouse iRhom2
has also been shown to promote the exit of TNF-converting enzyme from
the ER to the Golgi, where it is activated by furin-mediated proteolysis.
Right: RHBDL4 is an active rhomboid protease in the ER that cleaves select
membrane proteins with atypical, positively charged transmembrane
domains. The proteolytic fragments are subsequently degraded by the protea-
some as in classical ERAD pathways. RHBDL4, which presumably recognizes
ubiquitinated substrates via its UIM, also interacts with p97, which likely
promotes dislocation of RHBDL4-cleaved proteins from the ER membrane.
A common theme for RHBDL4 and rhomboid pseudo-proteases in the ER
seems to be in the regulation of substrate flux through the secretory pathway.
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PreviewsERAD) relies on ubiquitina-
tion, dislocation to the cyto-
sol, and degradation by the
26S proteasome. However,
in a recent issue of Molecular
Cell, Fleig and colleagues
(2012) revive interest in the
concept of intralumenal pro-
tein degradation in the ER
by providing evidence that
a rhomboid protease located
in the ER can cleave select
proteins in their transmem-
brane domains leading to ap-
parently lumenal proteolytic
intermediates and thereby
contributing to UPS-medi-
ated ERAD (Figure 1).
The importance of ERAD is
underscored by the ER stress
that occurs when ERAD is
insufficient. Such stress is
implicated in diseases includ-
ing cancer, neurodegenera-
tion, diabetes, and other
metabolic disorders. During
ER stress, cells attempt to
restore homeostasis by initi-
ating a multipronged un-
folded protein response
(UPR); when the UPR fails to
restore homeostasis, cell
death pathways are activated
(reviewed in Tsai and Weiss-
man, 2010). ERAD involves
convergent pathways that
target both lumenal andtransmembrane proteins for degradation.
For transmembrane proteins, the cyto-
solic region is believed to be a primary
site for ubiquitination, leading to the
binding of a cytosolic AAA-ATPase com-
plex consisting of a p97 hexamer and its
associated factors. The p97 complex is
thought to ‘‘ratchet’’ substrates from
the ER membrane, presumably through
an aqueous channel. Dislocated sub-
strates are ultimately degraded by the
proteasome.
There is increasing appreciation for
the importance of intramembrane pro-
teolysis in both cellular homeostasis and
signaling (reviewed in Lemberg, 2011;
Brown et al., 2000). In the ER, signal
peptide peptidase (SPP) cleaves signal
peptides characteristic of most secreted
and type I transmembrane proteins. In
the Golgi, two related enzymes—site-1
and site-2 proteases (S1P and S2P)—areimplicated in the cleavage and activation
of transcription factor precursors SREBP
(S1P and S2P) and ATF6 (S2P), which
are transported from the ER to the
Golgi in response to low levels of sterol
precursors or to ER stress, respectively.
Another enzyme involved in such cleav-
age is g-secretase. This multi-subunit
protease, in its various forms, is charac-
terized by a common enzymatic subunit,
presenilin, and cleaves proteins includ-
ing amyloid protein precursor, releasing
Alzheimer’s disease pathogenic Ab
peptides into the extracellular milieu, and
Notch, releasing the transcriptional acti-
vator NICD.
Fleig and colleagues (2012) now
report that the rhomboid protease
RHBDL4 resides in the ER and contrib-
utes to the proteolysis of several ectopi-
cally expressed ERAD substrates with
atypical, positively charged transmem-Developmental Cell 23, September 11,brane domains (Figure 1).
Rhomboid proteases repre-
sent a family of polytopic
intramembrane serine prote-
ases and pseudo-prote-
ases (reviewed in Lemberg,
2011). The first described
member of this family was
Rhomboid-1, initially identi-
fied in Drosophila, which
catalyzes the release of
growth factors from their
transmembrane precursors
in the Golgi. Rhomboid prote-
ases are found in many
membrane-limited organelles
including the mitochondria,
where, in mammals, pre-
senilin-associated rhomboid-
like (PARL) cleaves OPA1,
which regulates mitochon-
drial cristae integrity and
apoptosis (Cipolat et al.,
2006). Catalytically inactive
members of the rhomboid
family, iRhoms and Derlin-1,
are rhomboid pseudo-prote-
ases implicated in ERAD
(Figure 1) (Greenblatt et al.,
2011; Zettl et al., 2011).
Mouse iRhom2 has also
been implicated in the traf-
ficking of TNF-converting
enzyme from the ER to the
Golgi, where it is activated
by proteolysis (Adrain et al.,
2012).Unlike the iRhoms and Derlin-1,
however, RHBDL4 requires its serine
protease activity to enhance protein
destruction. Fleig and colleagues (2012)
show that RHBDL4 cleaves ERAD sub-
strates, including pre-T cell receptor
a (pTa), a type I transmembrane protein,
as well as polytopic proteins, resulting
in multiple N-terminal proteolytic frag-
ments. The authors find that p97, re-
cruited by interaction with a C-terminal
binding motif of RHBDL4, is required for
proteasomal degradation of these frag-
ments, probably by facilitating their dislo-
cation from ER membranes. Consistent
with a role in ERAD, RHBDL4 is induced
by the UPR and knockdown of RHBDL4
activates the UPR, suggesting that it
may enhance ERAD of select proteins
under conditions of ER stress. Moreover,
they show that placement of positively
charged amino acids into a normally2012 ª2012 Elsevier Inc. 455
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Previewsuncharged transmembrane domain can
render a protein a substrate for RHBDL4.
It is suggested that RHBDL4 is respon-
sible for proteolytic breakdown beyond
the initial cleavage; however, this remains
to be determined.
Perhaps most striking about RHBDL4,
and what distinguishes it from other
known intramembrane proteases, is its
ubiquitin-interacting motif (UIM). Fleig
and colleagues (2012) find that the UIM
is required for RHBDL4 function in
protein degradation. Overexpression of
an inactive protease mutant of RHBDL4
accumulates ubiquitinated substrates,
suggesting that substrate ubiquiti-
nation is required for recognition by
RHBDL4. This added layer of complexity
to ERAD therefore continues to rely
on ubiquitination to initiate substrate
degradation.
RHBDL4 and its role in generating
lumenal degradation intermediates
necessarily leads us to question assump-
tions about ERAD. Particularly, whether
ERAD is solely the province of 26S protea-
some activity toward fully intact proteins
dislocated from the ER and whether
lumenal-intramembrane and cytosolic-456 Developmental Cell 23, September 11, 20nuclear proteolysis might function coordi-
nately in protein degradation to a greater
extent than generally appreciated. Inter-
estingly, a previous report demonstrated
that SPP could play a role in ERAD of
ectopically expressed TCR-a, which also
has a positively charged transmembrane
domain (Loureiro et al., 2006). It is now
interesting to assess the range of intra-
membrane ER proteases and substrates
that might be responsible for, or targets
of, intramembrane cleavage as part of
ERAD.
It is important, however, to note that
bona fide endogenous substrates for
RHBDL4 have yet to be identified, and
the proteasome is sufficient to compen-
sate for RHBDL4 knockdown in degrada-
tion of substrates. Therefore, the overall
significance of this protease in ERAD
awaits determination. Beyond this, much
of the known intramembrane or juxta-
membrane proteolysis serves roles in
either signaling or protein processing.
Thus, whether RHBDL4 functions
primarily in protein degradation versus
ubiquitin-dependent protein processing
and signaling pathway(s) becomes of
great interest. The provocative findings12 ª2012 Elsevier Inc.of Fleig and colleagues (2012) will no
doubt spur further studies to decipher
the functions of RHBDL4 in physiological
contexts.REFERENCES
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